Airway Therapeutics logo

Airway Therapeutics

Developing a new class of biologics for patients with respiratory and inflammatory diseases.

11 employees · est. 2011 · Cincinnati, United States

VS
Antlia Bioscience, Inc. logo

Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases

4 employees · est. 2021 · Encinitas, United States

Airway Therapeutics is the older company (2011 vs 2021); Airway Therapeutics is the larger of the two.

Side-by-Side Comparison

Airway Therapeutics Antlia Bioscience, Inc.
Founded
2011 older 2021
Headquarters
Cincinnati, United States Encinitas, United States
Employees
11 larger 4
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Health Care
Funding Stage
Series C Not tracked yet
Total Funding
$38.78M Not tracked yet
Funding Rounds
6 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biologics, Respiratory Diseases, Inflammatory Diseases, Protein Development, Bronchopulmonary Dysplasia, Pediatrics, Licensing Technology, Pulmonary Research, Pediatric Drug Development, Orphan Drug Development, Pulmonary Therapies, Protein Drug Development, Neonatal Drug Therapy, Inhalation Drug Delivery Therapeutics, Peptides, Chronic Diseases, PASylation®, Pharmacokinetics, Cardiovascular Diseases, Pulmonary Diseases, Metabolic Diseases, Drug Development, Science, Innovation, Pharmaceuticals
Website
airwaytherapeutics.com antliabio.com
Airway Therapeutics logo

About Airway Therapeutics

Airway Therapeutics is a biotechnology startup founded in 2011 and headquartered in the United States. The company’s focus is on developing a new class of biologics for patients with respiratory and inflammatory diseases. Born as a spin-out of Cincinnati Children's Hospital Medical Center (CCHMC), A...

Antlia Bioscience, Inc. logo

About Antlia Bioscience, Inc.

Antlia Bioscience, Inc. is a biotechnology startup founded in 2020 with a mission to develop revolutionary therapeutics for chronic diseases. Utilizing its proprietary chemistry platform, PASylation®, the company is focused on engineering long-acting peptides with refined pharmacologic and pharmacok...

We will tell you when either one moves

BounceWatch watches Airway Therapeutics and Antlia Bioscience, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Airway Therapeutics and Antlia Bioscience, Inc... — by email.

Frequently Asked Questions

Airway Therapeutics — Developing a new class of biologics for patients with respiratory and inflammatory diseases.. Antlia Bioscience, Inc. — Turning promising peptides into groundbreaking therapeutics for chronic diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Airway Therapeutics has raised $38.78M while Antlia Bioscience, Inc. has raised undisclosed funding.
Airway Therapeutics and Antlia Bioscience, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Airway Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Airway Therapeutics on 13 Sep 2024, and Antlia Bioscience, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes